The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
about
Nonalcoholic fatty liver disease and hepatocellular carcinomaNonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsNon-alcoholic fatty liver disease: what the clinician needs to know.Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort studySurveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver CirrhosisMolecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesThe Natural Course of Non-Alcoholic Fatty Liver DiseaseSurveillance for Hepatocellular Carcinoma in Patients with NASHHepatocellular Carcinoma: Risk Factors, Diagnosis and TreatmentNew advances in hepatocellular carcinomaVascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinNovel Molecular Mechanisms in the Development of Non-Alcoholic SteatohepatitisEarly Detection of Hepatocellular Carcinoma: How to Screen and Follow up Patients with Liver Cirrhosis According to the GERMAN S3 Guideline?Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinomaManagement of hepatocellular carcinoma in the elderlyPrevention of hepatocellular carcinoma: Focusing on antioxidant therapyNutrition and metabolism in hepatocellular carcinomaContributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancerAlcoholic and non-alcoholic steatohepatitisNon-alcoholic fatty liver disease: a practical approach to diagnosis and stagingEffect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD)Radiological diagnosis of hepatocellular carcinomaHepatocellular carcinoma in patients with non-alcoholic fatty liver diseaseNASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?Effectiveness and safety of controlled venous pressure in liver surgery: a systematic review and network meta-analysisPrevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populationsDickkopfs and Wnt/β-catenin signalling in liver cancerNIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLDBiological networks for predicting chemical hepatocarcinogenicity using gene expression data from treated mice and relevance across human and rat speciesRecommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisMulti-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver diseaseHepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic.NAFLD and liver transplantation: Current burden and expected challenges.Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine.Cost-utility analysis of nonalcoholic steatohepatitis screening.Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.
P2860
Q21284740-F44F1E0A-A16D-494C-9F7A-7D01EB97238AQ22299426-A4D4D8E8-BD0D-4E8B-8915-E7E8C906A907Q24563068-34734060-8BDF-49A3-BA59-227AEBC2F1A1Q24596256-9D3DBC81-5626-47C3-8F22-61B9F800E838Q26740317-462CE20D-2731-4A26-9ECB-99872877047BQ26745338-33DC888F-8E28-4F33-BE6F-5DFBC598E4BDQ26746947-2EE7B748-BD14-4E3F-8103-8E9F4A0AA7A8Q26747428-A69B3070-EF50-4278-8223-3680674CBC82Q26747551-698CA8ED-0B7C-4A87-886F-D20086BBEDAFQ26749329-DB045F73-3000-4192-BA2F-A1F50B481A28Q26750865-4408AD69-0D0B-4DF6-B8E2-94BCFA9F689DQ26766533-4AB3154A-C555-4F19-A6EA-692B31C32DCBQ26768466-BF8AE7F0-2866-4309-B3E9-7F0690327E11Q26780252-DFD80E58-A45B-459B-87D8-91325623AF34Q26795529-736B8814-A9B6-4B19-B79D-EA9E069F8780Q26827161-907B71F8-443F-4A5D-BA19-960FDE3D3429Q26853520-E75AA013-24AE-4BE5-9A87-EB2A1ABB65C6Q26862862-6C721E88-3CED-4B1B-9168-4F879071CF17Q26992106-818DFE49-03A6-49F1-A141-C62C77AB20D9Q27000153-44AB8627-9413-434A-9E69-B8AA4AE6779CQ27006131-C957F6A6-FE01-4803-9E03-AEA5C6DB6DA5Q27021000-A3369B6D-8FDC-462F-A8FD-D293B2F4B67DQ27027683-DC528832-831B-45F0-A8F7-60A86C9EC184Q28066100-1B7BCEA9-18AC-4CFF-B291-44F2969B2916Q28079900-85A7220F-9518-4A48-A261-9399BF1B836DQ28088368-F0EBBC1E-94A5-40CD-9425-1DA669DB656EQ28384968-3F62CD83-177A-44DA-8274-85AE27EBB992Q28386598-C879F569-A1A9-423B-B490-644E39BC40FEQ28391394-3E998273-FE0E-4432-89C3-0AD03C79E84FQ28488938-5F699D1F-4795-4C88-8F5B-6864DD69B748Q28533447-19EA18FE-83B6-4E0F-BA8E-8391C9F9C784Q28607750-23E25A91-2244-4A87-8941-E41DEC2995F5Q30000787-A8E746DD-DD4A-465A-A5F0-66E78227352EQ30234574-48AEED29-EDA7-4C3D-B4A3-37017763CE81Q30238933-D9FD4475-753D-433E-91A9-A8CEAE288A14Q30248646-C1E9AABA-8A5B-466A-AA85-052C02C3227BQ30301218-C77414F9-8B37-4D56-9417-BAE5055B2E92Q30385602-DBF4DA70-3BB9-41FF-90EC-D3B776DB474DQ30392056-922160CB-CCC8-49BB-A8A5-A7C973E0BC52Q30412709-53BFCB2B-05E6-46DC-BDD3-C450E1F10503
P2860
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The incidence and risk factors ...... nonalcoholic steatohepatitis.
@ast
The incidence and risk factors ...... nonalcoholic steatohepatitis.
@en
The incidence and risk factors ...... nonalcoholic steatohepatitis.
@nl
type
label
The incidence and risk factors ...... nonalcoholic steatohepatitis.
@ast
The incidence and risk factors ...... nonalcoholic steatohepatitis.
@en
The incidence and risk factors ...... nonalcoholic steatohepatitis.
@nl
prefLabel
The incidence and risk factors ...... nonalcoholic steatohepatitis.
@ast
The incidence and risk factors ...... nonalcoholic steatohepatitis.
@en
The incidence and risk factors ...... nonalcoholic steatohepatitis.
@nl
P2093
P356
P1433
P1476
The incidence and risk factors ...... nonalcoholic steatohepatitis.
@en
P2093
Ariel F Feldstein
Ibrahim A Hanouneh
Mustafa S Ascha
Nizar N Zein
Rocio Lopez
Tarek Abu-Rajab Tamimi
P304
P356
10.1002/HEP.23527
P407
P577
2010-06-01T00:00:00Z